← Evidence map

ArticleStatistics in medicine2021

Seamless phase I/II design for novel anticancer agents with competing disease progression.

Lucie Biard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34213022